4th InterAmerican Oncology Conference

“Current Status and Future of Anti-Cancer Targeted Therapies”
6-7 October, 2011

Conference Chairmen

Román Perez Soler, New York, USA
Carlos L. Arteaga, Nashville, USA

Under the Auspices of

Academia Nacional de Medicina
Asociación Médica Argentina
Chemotherapy Foundation (USA)
Sociedad de Hematología
Sociedad de Urología
Sociedad de Medicina Interna de Buenos Aires.
Declared of special scientific interest by Facultad de Medicina, University of Buenos Aires


Alex A. Adjei, M.D., Ph.D.
Professor and Chair, Department of Medicine
Katherine Anne Gioia Chair in Cancer Medicine
Roswell Park Cancer Institute
Buffalo, NY, USA

Kenneth C. Anderson, M.D.
Kraft Family Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, USA

Carlos L. Arteaga, M.D.
Professor of Medicine and Cancer Biology
Interim Director, Division of Hematology-Oncology
Director, Breast Cancer Program
Vanderbilt-Ingram Cancer Center
Vanderbilt University
Nashville, Tennesse, USA

Fernando Cabanillas, M.D.
Clinical Professor of Medicine
University of Texas M. D. Anderson Cancer Center
Houston, Texas, USA
San Juan, Puerto Rico

Jorge Cortes, M.D.
Professor of Medicine
Chief, CML & AML Sections
Deputy Chair, Department of Leukemia
MD Anderson Cancer Center
Houston, Texas, USA

Hernán Cortés Funes, M.D.
Department of Medical Oncology
Hospital Universitario “12 de Octubre”
Madrid, Spain

Jorge A. Garcia, M.D.
Department of Solid Tumor Oncology and Urology
Cleveland Clinic Taussig Cancer Institute
Cleveland Clinic Glickman Urological & Kidney Institute
Assistant Professor of Medicine
Lerner College of Medicine
Cleveland, Ohio, USA

Axel Grothey, M.D.
Professor of Oncology
Division of Medical Oncology
Mayo Clinic, Rochester, Minnesota
Vice Chair, North Central Cancer Treatment Group
Co-chair, NCCTG GI committee
Rochester, Minnesota, USA

Josep LLovet, M.D.
Professor of Research, ICREA
BCLC Group, Liver Unit, IDIBAPS.
CIBERehd, Hospital Clínic
Barcelona, Spain
Director, Mount S inai Liver Cancer Research Program.
Mount Sinai School of Medicine,
New York, USA
Barcelona, Spain

Edith Perez, M.D.
Serene M. and Frances C. Durling Professor of Medicine
Deputy Director, Mayo Clinic Cancer Center
Mayo Clinic
Jacksonville, Florida, USA

Roman Perez-Soler, M.D.
Chairman, Departamen of Oncology
Monteriori Medical Center
Albert Einstein College de Medicine
Bronx, NY, USA

Antoni Ribas, M.D.
Associate Professor of Medicine and Surgery at UCLA
Director, Tumor Immunology Program Area
Jonsson Comprehensive Cancer Center (JCCC)
Director, Cell and Gene Therapy Manufacture Core Facility
Los Angeles, California, USA

Joyce O’Shaughnessy, M.D.
Co-Director of the Breast Cancer Research Program
Baylor-Charles A Sammons Cancer Center
US Oncology,
Dallas, Texas, USA

Josep Tabernero, M.D.
Medical Oncology Department
Vall d’Hebron University Hospital
Barcelona, Spain


The supporting companies have no control over the selection of the faculty or the content of the presentations.


Boehringer IngelheimCelgeneMerkRoche





Diagnostico Maipu